Manfred Windisch

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Niklas Mattsson, Ulf Andréasson, Staffan Persson et al. · Alzheimer s & Dementia · 2011 · 406 citations · Full text

CSF biomarker variability in the Alzheimer's Association quality control program

Niklas Mattsson, Ulf Andréasson, Staffan Persson et al. · Alzheimer s & Dementia · 2013 · 380 citations · Full text

Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology

Stephan Schilling, Ulrike Zeitschel, Torsten Hoffmann et al. · Nature Medicine · 2008 · 345 citations

Glutaminyl Cyclase Inhibition, Neurodegenerative Diseases, Molecular Neuroscience +10

The ACAT Inhibitor CP-113,818 Markedly Reduces Amyloid Pathology in a Mouse Model of Alzheimer's Disease

Birgit Hutter‐Paier, Henri J. Huttunen, Luigi Puglielli et al. · Neuron · 2004 · 270 citations · Full text

Alzheimer's Disease, Medicine, Dementia +9

Acute Cerebrovascular Disease in the Young

Arndt Rolfs, Franz Fazekas, Ulrike Grittner et al. · Stroke · 2013 · 210 citations · Full text